Release Date: 20/04/10 13:04 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 49.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%